Important: 9th Annual Global Pharma Regulatory Summit Update

Due to the recent and increasing travel restrictions and health advisories from multiple governments, Informa Markets in India has taken the difficult decision to postpone the 9th Annual Global Pharma Regulatory Summit (originally scheduled for 27-29 May, 2020 at The Courtyard by Marriott). Having spent over more than 6 months in curating the Conference with our advisory boards, speakers, and event partners, we're genuinely saddened not to be able to host you at this time.

We want to thank all our customers and partners for their support and encouragement. As everyone has been reminding us, great things happen when the community comes together and connects at our conferences. For this reason, we fully intend to conduct the Global Pharma Regulatory Summit on 19-21 August, 2020.

For additional questions, comments, and concerns please contact:

For Partnership inquiry, please email
Sakshi.chourasia@informa.com
For Delegate support, please email
nigel.fernandes@informa.com
For Speaking inquiry, please email
ankheeta.lath@informa.com
For Marketing inquiry, please email
Meghna.dekhtawala@informa.com

Industry Landscape

Globally, Indian pharma has contributed to improve public health outcomes. India accounts for 60% of global vaccine production, contributing 40 to 70% of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of the WHO demand for the measles vaccine. Estimates suggest that one in every three pills consumed in the United States is produced by an Indian generics manufacturer. In the UK, approximately 25% of the medicines used are made in India.


Why this Forum

The 9th Edition Global Pharma Regulatory Summit organized by CPhI Conferences will witness a gathering of senior leaders and experts of regulatory affairs, compliances, quality assurance and policy makers to discuss and share their perspectives on current trends and challenges in global regulatory landscape. The themes are designed to inspire and enable the brilliant minds from across the pharma ecosystem to come together to examine, discuss and debate how to improve regulatory system and lower the challenges associated


Who Should Partner

Enterprise Solutions

Regulatory solutions
Regulatory solutions
Legal firms
Legal firms
Pharma consultants
Pharma consultants
Data management
Data management
Software and technology
Software and technology
R&D solution providers
R&D solution providers

Who Should Attend?

The 9th Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. These delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.

Designation


VP’s; Directors; HODs
Sr. Managers / General Managers
Managers/ Deputy Managers
Executives

Programme Focus


Advisory Board Members & Speakers


Why Attend

Access the latest information and insights on global regulatory affairs program

Analyze how stakeholders around the world are supporting regulatory system optimization

Examine the impact of new initiatives for emerging markets

Network with innovators and opinion leaders in the pharma regulatory affairs arena

Glimpses & Testimonials


Glimpses

GET YOUR DELEGATE BROCHURE

Full speaker list • Full conference agenda

GET YOUR SALES BROCHURE

Full speaker list

GET POST SHOW REPORT

Full speaker list